Liraglutide and exenatide are potent medications classified as GLP-1 receptor agonists. These pharmaceutical agents mimic the effects of naturally generated glucagon-like peptide-1 (GLP-1), a hormone crucial for regulating blood glucose levels. Both liraglutide but also exenatide demonstrate efficacy in managing type 2 diabetes by stimulating the r